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Abstract 
Lactic acid bacteria are normal inhabitants of the gastrointestinal tract of humans. Their occurrence in infant and 
adult feces is abundant. The current study assesses and compares the antibiotic resistance in lactic acid bacteria 
isolated from healthy human adult and healthy infant fecal samples. A total of 255 lactic acid bacteria isolates (126 
from adult feces and 129 from infant feces) were isolated and characterized from 60 fecal samples. Lactobacillus spp., 
Pediococcus spp. and Enterococcus spp. were included in the study. The study was done using the WHONET software 
for the analysis of antibiotic susceptibility data of lactic acid bacteria. Most of the Lactobacillus and Pediococcus strains 
were sensitive to vancomycin. Enterococcus strains showed resistance against vancomycin. Ampicillin, ciprofloxacin 
and cefuroxime resistance were significantly (p<0.05) higher in Lactobacillus strains isolated from adult fecal samples 
than those isolated from infant fecal samples. A similar pattern was observed in Enterococcus strains with 
erythromycin, gentamycin and tobramycin resistance. Pediococcal isolates from adult feces showed significantly 
higher resistance against tobramycin, ciprofloxacin, gentamycin, cefotaxime and cefuroxime in comparison with 
infant fecal isolates. Antibiotic resistance was exhibited by lactic acid bacteria against most commonly used 
antibiotics and it was higher in strains isolated from adult fecal samples than in the strains isolated from infant fecal 
samples. The increasing trend in antibiotic resistance from infant to adult might be due to food habits and antibiotic 
intakes. Thus, the widespread antibiotic resistance in different lactic acid bacteriamay pose a food safety concern as 
well. 
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Introduction 
The lactic acid bacteria (LAB) originate from a 
taxonomically diverse group of microorganisms, 
which are non-sporing rods and cocci, usually non-
motile that ferment carbohydrates and form lactic 
acid. Lactic acid bacteria contain the genera namely 
Lactobacillus, Lactococcus, Pediococcus, Streptococcus, 
Enterococcus, Oenococcus, Leuconostoc, 
Carnobacterium, Vagococcus, Tetragenococcus, and 
Weissella [1]. The microflora of humans and animal 
gut is complex and it is primarily dominated by 
lactic acid bacteria. There is high density and rich 
diversity of microorganisms in the gut, and the 
microflora complexity increases from the upper 
gastrointestinal tract to the colon [2]. The human gut 
contains more than a thousand bacterial species and 
some of them start to colonize the gut during infancy 
[3]. Soon after the birth of a newborn infant, the gut 
flora begins to develop and microbes start to 
colonize the small intestine and large intestine. 
Aerobic and facultative anaerobic bacteria 
(Enterobacteria, Enterococci and Streptococci) are the 
early colonizers in the human gut. After they 
colonize, they create anaerobic environment in the 
gut. This helps anaerobic bacteria 
(Bifidobacteria, Bacteroides and Clostridia) to start with 
their colonization majorly in the large intestine [4]. 
The development of complex, diverse and stable 
microflora continues from infancy to one year of age. 
After a year it is similar to adults and it is stable [4]. 
Many factors are governing the development, 
diversity, composition and colonization gut 
microflora of infants, out of which mother’s gut 
microflora, food and environment are the deciding 
ones [5]. During birth, an infant is exposed to the 
mother’s vaginal microflora and also to fecal 
microflora, and with this exposure colonization of 
the gut in infants begins [6]. Infant gut microflora is 
affected by colostrum and later by breast milk. After 
the introduction of formula and solid foods, 
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complexity and diversity is generated in the gut 
microflora of infants. Microbes present in the 
environment and those present directly on the skin 
of the infant also enter the gut and create a complex 
niche [7]. Colonization of the gut with diverse 
microflora creates continuous impacts on the 
immune system; and in this process, it strengthens 
the immune system [8]. 
Over the past few decades, there has been a huge 
interest developed in LAB physiology and genetics, 
involving their increasing importance as starter 
cultures in different industrial fermentation 
processes and also as probiotics. Since probiotics are 
directly administered in humans and animals it is 
very necessary to determine the level of antibiotic 
resistance. This is a part of the assessment of the 
safety of the probiotic cultures which are 
administered as therapeutics.  
In the past 60 years, approximately 10 million tons of 
antibiotics have been utilized and released into the 
environment. As presented in the reports of 
European Commission there is a huge probability of 
the spread of antibiotic resistance in the biosphere 
[9]. Hence,there is a very strong selective pressure in 
the development of antibiotic resistance in bacterial 
strains [10]. 
Lactic acid bacteria dominate the gastrointestinal 
tract of humans. They are present in large amounts 
in the gut and are also added or sometimes 
additionally consumed along with the regular diet. 
Hence, it is speculated that the presence of antibiotic 
resistance in lactic acid bacteria used as probiotics 
can be dangerous. Probiotics are generally 
administered to maintain microbial balance during 
gastrointestinal tract infections such as diarrhea.  
They are administered as therapeutic agents along 
with antibiotics. If probiotics harbor antibiotic-
resistant genes, it could be beneficial in sustaining 
the antibiotics during the treatment; however, there 
is a risk of antibiotic-resistant probiotic strains to 
transfer the resistance genes to the pathogenic 
bacteria. This could complicate the treatment of a 
patient with an antibiotic-resistant bacterial 
infection or disease. Additionally, there is the 
possibility of the transfer of antibiotic resistance 
from beneficial lactic acid bacteria, in the food chain. 
Therapy with any antibiotic, particularly long term 
and especially oral administration is liable to alter 
the balance of antibiotic-resistant to sensitive 
organisms in the intestine [11]. 
Certain strains of these genera are more commonly 
used in the food and especially dairy industries or as 
probiotics [12]. The World Health Organization 
(WHO) has established a program known as the 
Antimicrobial Resistance Monitoring (ARM) 
program for monitoring antimicrobial resistance. 
WHO has also devised an electronic format 
WHONET, freely available to download. A special 
focus of antimicrobial susceptibility test results is 
available on windows-based database software, 
developed for the management and analysis of 
microbiology data [13]. This study aimed to 
determine the antibiotic susceptibility of lactic acid 
bacteria (using WHONET software) isolated from 
adult and infant feces to various groups of 
antibacterial agents that are mainly isolated from the 
feces of breastfed infants. Also, the comparative 
assessment was done to determine the isolates that 
are more resistant to antibiotics.  
Materials and Methods 
Sample collection and ethics statement  
Thirty healthy adult human volunteers (from 
Mumbai and Suburbs, India) aged between 25 and 
30, who were not suffering from any chronic disease, 
had not taken antibiotics, proton pump inhibitors, 
bismuth compounds, Histamine H2-receptor, 
nonsteroidal anti-inflammatory drugs within the 
previous 6 months, were selected for the study. 
Similarly, fecal samples were also collected from 
thirty healthy infants aged between 3 months to 9 
months. Infants who were exclusively breast-fed, 
healthy and free from acute or chronic disease were 
selected in the study. The study protocol was 
approved by an independent ethical committee and 
performed in compliance with the US Code of 
Federal Regulations on Good Clinical Practices (21 
CFR 10.90, 50, 56 and 812) and the World Medical 
Association Declaration of Helsinki (1996 
amendment) [14]. All adult volunteers and parents 
of infants signed informed consent before samples 
were collected. 
Isolation of lactic acid bacteria from the 
fecal sample 
Fecal samples were collected in sterile 
polypropylene containers and processed 
immediately as follows. A 0.5 g portion of feces was 
taken from mid sample, added in 4.5 ml of sterile  
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saline solution, and completely homogenized. A 
dilution series (10–1 to 10–7) was made and 100 µl  
 aliquots of each dilution were inoculated on the 
agar plates by spread plating. Rogosa SL agar (Hi-
Media, Mumbai, India) was used to isolate LAB and 
the plates were incubated micro-aerobically for 3 
days at 37°C. Kenner fecal (KF) agar was used for the 
isolation of Enterococcus and incubated aerobically at 
37°C for 24 h [15].  
 Enumeration and selection of bacterial 
isolates 
 After incubation, the plates that showed discrete 
colonies were selected and the colonies were 
counted. The total count of Lactic acid bacteria in 
feces was expressed as colony-forming units/g (wet 
weight). From each fecal sample, 10-20 colonies of 
LAB were randomly selected. A provisional 
identification of genera was made based on Gram’s 
staining, and catalase reaction using 3% (v/v) H2O2 
on single colonies. Putative Lactobacilli colonies 
(Gram-positive, catalase test-negative, rod-shaped) 
were chosen and further purified using MRS agar. 
Similarly, putative colonies of Enterococci and 
Pediococci (Gram-positive, catalase test-negative, 
cocci, able to grow at 10oC and 45oC, and in 18% 
NaCl and at pH 4.4) from KF agar plates were 
purified by re-streaking on the MRS agar. The 
cultures were stored in MRS broth with 15% glycerol 
at –20°C [15]. 
Antibiotic resistance 
 The antibiotic resistance/susceptibility patterns of 
isolated strains of lactic acid bacteria were studied 
using the Kirby-Bauer disk diffusion method 
(according to the CLSI document M2-A9 
suggestions) [16]. The antibiotics used in this study 
were penicillin (10 µg), ampicillin (10 µg), 
vancomycin (30 µg), cefuroxime (30 µg), cefotaxime 
(30 µg), ciprofloxacin (5 µg), gentamycin (10 µg), 
tobramycin (10 µg), erythromycin (15 µg) and 
chloramphenicol (30 µg). The culture densities were 
adjusted to McFarland 1.5; they were spread on MRS 
agar plates. Antibiotic discs (Hi-Media, Mumbai, 
India) were placed on the surface of the agar plates, 
which were incubated at 37°C for 24 h. The 
diameters of the clearance zones around the discs 
were measured and the result (the average of 2 
readings) was expressed as susceptible, 
intermediate, or resistant according to the standard 
disc diffusion method [16]. The experiment was 
done in triplicates. Microsoft Excel (2013) was used 
to obtain data in the appropriate format for BacLink 
2019, used to format data to be used in WHONET 
2019, which automatically calculates the % 
resistance using a data analysis tool. 
Statistical analysis 
The data was analyzed to check the significant 
difference between groups using Student’s T-test 
with a probability level of 0.05 (P < 0.05) using 
Microsoft Excel (2013). 
Results  
Isolation of lactic acid bacteria from the 
fecal sample 
A total of 255 LAB isolates were isolated from 30 
human adult and 30 human infant fecal samples. 
Out of the 255 isolates, 126 isolates were from the 
adult fecal sample, and 129 from the infant fecal 
sample, the results are presented in Table 1. The 
isolates were identified phenotypically and 
characterized. Based on the characters, the LAB 
isolates were characterized as mesophilic 
homofermentative cocci, able to grow at 10oC and 
45oC as Enterococcus (81 isolates). Homofermentative 
cocci in tetrads, unable to grow in 18% NaCl, and 
showing growth at pH 4.4 were characterized as 
Pediococcus (84 isolates). Lactobacilli (90 isolates) 
were represented as catalase-negative, slender 
gram-positive rods. All strains grew at 4oC and 6.5% 
NaCl concentration. 
Antibiotic resistance of lactic acid 
bacteria 
Data of diameter of zone of clearance in mm of LAB 
isolated from adult and infant feces was entered in 
Microsoft Excel and via BacLink software 
incorporated into WHONET software (Table 2).  
Table 1. Count of LAB isolates in the adult and infant fecal samples. 
Sample source Number of samples 
(n = 60) 
LAB isolates 
(n = 255) 
Lactobacillus spp. 
(n=90) 
Pediococcus spp. 
(n=84) 
Enterococcus spp. 
(n=81) 
Adult feces 30 126 46 41 39 
Infant feces 30 129 44 43 42 
*LAB= Lactic Acid Bacteria 
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Figure 1. Antibiotic resistance pattern of Pediococcus spp. 
(a), Lactobacillus spp. (b) and Enterococcus spp. (c) isolated 
from adults and infant feces, respectively [AMP-
Ampicillin, CHL-Chloramphenicol, CIP-Ciprofloxacin, 
CTX-Cefotaxime, CXM-Cefuroxime, ERY-Erythromycin, 
GEN-Gentamicin, PEN-Penicillin G, TOB-Tobramycin, 
VAN-Vancomycin]. All experiments were performed in 
triplicates and the error bar represents the standard 
deviation of independent performs experiments (n=3). 
Pediococcus spp. isolated from adult feces was 
comparatively more resistant to antibiotics than 
those isolated from infant feces. Significantly higher 
resistances (P < 0.05) were found against ampicillin 
(7.3%), cefotaxime (22.0%), cefuroxime (36.6%), 
penicillin (12.2%) gentamycin (26.8%), erythromycin 
(19.5%), tobramycin (29.3%) and ciprofloxacin 
(26.8%) from isolates from adult feces than those 
isolated from infant feces, 7.0%, 9.3%, 0.0%, 11.6%, 
9.3%, 0.0%, 2.3% and 20.9% respectively (Figure 1a). 
All the isolates from both adult and infant samples 
were sensitive to vancomycin and chloramphenicol. 
Pediococcus spp. were intrinsically resistant to high 
levels of glycopeptides and penicillin. Resistance to 
erythromycin was also reported and was due to a 
plasmid with an erythromycin resistance methylase 
B [erm(B)] gene [17]. 
Discussion 
To develop probiotics for human or animal 
consumption, it is necessary to distinguish strains 
harboring antibiotic resistance genes from other 
strains because of potential risk for the 
dissemination of resistance genes. In this study, it 
was demonstrated that strains isolated from infants 
were more sensitive than those isolated from adult 
feces. Lactobacilli and Pediococciare widely used as 
probiotics and promoters for biological growth. 
Lactobacilli are reported to be resistant to several 
antibiotics [18]. In the present study, Lactobacillus 
spp. isolated from adult feces were more resistant to 
antibiotics than those isolated from infant feces. 
Significantly higher resistance was found against 
cefuroxime (26.1%) and ciprofloxacin (32.6%) from 
isolates from adult feces than those isolated from 
infant feces, 4.5%, and 2.3% respectively. 
Lactobacillus spp. isolated from feces also showed 
moderate resistance to cefotaxime (13.0%), penicillin 
(10.9%), chloramphenicol, (10.9%), gentamycin 
(23.9%), erythromycin (13.0%) and tobramycin 
(26.1%). Whereas those isolated from infant feces 
showed comparatively lesser resistance 4.5%, 11.4%, 
9.1%, 20.5% and 9.1%, respectively (Figure 1b). 
Resistance to gentamycin and ciprofloxacin was 
earlier documented [19, 20]. Concerning cell wall 
synthesis inhibitors, Lactobacilli are reported to be 
resistant to oxacillin and cephalosporins (cefoxitin 
and ceftriaxone) [21].   
They were also found to show resistance to 
aminoglycosides (neomycin, kanamycin, 
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streptomycin, and gentamicin) [22]. There are many 
species of Lactobacilli which contain intrinsic 
resistance to vancomycin, erythromycin and 
tetracycline. The matter of concern is that since 
Lactobacilli are added to infant food, they can act as 
reservoirs of antibiotic resistance genes, which could 
be transferable [23]. 
Enterococcus spp. also followed a similar pattern 
where the antibiotic resistance associated with adult 
fecal samples was higher than those isolated from 
infant feces. Adult fecal isolates were 30.8% resistant 
to erythromycin, 20.5% resistant to tobramycin, and 
41% resistant to gentamycin. This was significantly 
higher (P < 0.05) than infant fecal isolates, which 
were sensitive to erythromycin, 9.5% resistant to 
tobramycin, and 4.8% to gentamycin.  Higher 
resistance was also found against vancomycin 
(30.8%), ciprofloxacin (33.3%), ampicillin (28.2%), 
cefuroxime (20.5%) and cefotaxime (28.2%); 
however, it was not statistically significant in 
comparison to infant fecal isolates which showed 
11.9%, 9.5%, 21.4%, 9.8% and 26.2% resistance 
against above-mentioned antibiotics, respectively. 
All the isolates (fecal and adult) were susceptible to 
chloramphenicol. Infant isolates were 11.9% 
resistant to penicillin; this was higher than adult 
isolates, which showed 10.3% resistance (Figure 1c). 
Enterococci showed intrinsic and acquired 
resistance against many antibiotics [24, 25]. Such 
intrinsic resistance was reported inlincosamides, 
nalidixic acid penicillin, polymyxins, quinupristin–
dalfopristin, monobactams, and low levels of 
aminoglycosides. Resistance to high levels of 
aminoglycosides, high levels of trimethoprim, and 
high levels of clindamycin, chloramphenicol, 
tetracyclines, penicillins (due to β-
lactamase), fluoroquinolones, macrolides (e.g. 
erythromycin), glycopeptides and oxazolidinones 
(linezolid) were acquired [26-27].  Acquired 
resistance is a major threat in treatment, such a trait 
was found to be transferred to other Enterococci in 
the gut [28]. Vancomycin resistance is especially 
important as vancomycin is the last drug option for 
treating diseases caused by multidrug resistance 
Enterococci [29].  
Apart from probiotic use, Pediococci are also widely 
used for the fermentation of meat and vegetables 
and also in cheese production [30]. According to the 
EFSA’s FEEDAP Panel [31] (European Food Safety 
Authority Panel on Additives and Products or 
Substances used in Animal Feed), the bacterial 
cultures which are used for the production of animal 
feed should be susceptible to antibiotics used in 
treating humans bacterial infections. Hence, it is 
extremely necessary to distinguish antibiotic 
susceptible and resistant strains. This also 
emphasizes the importance of safe source or niche of 
a selection of strains used as probiotics. The results 
of the study indicate that infant feces could be a 
better source for isolation of LAB cultures intended 
to be used as probiotics. 
Apart from being used traditionally as starter 
cultures in dairy products, LAB are also used for the 
production of animal feed. They also belong to 
normal flora of the human gut and confer health 
benefits to the host. During the process of food 
manufacturing and passage of food through gut, 
there is a possibility of antibiotic resistance, carried 
by LAB getting transferred to human pathogenic 
bacteria [32]. Hence, it is imperative to select strains 
Table 2. Percent antibiotic resistance in target microorganisms isolated from adult and infant fecal samples. 
Expressed in percentage (%) 
Mechanism of 
Action  
Antibiotic Lactobacillus spp. Pediococcus spp. Enterococcus spp. 
Adult Infant Adult Infant Adult Infant 
Cell Wall 
Inhibitors 
Ampicillin 10.9 11.4 7.3 7.0 28.2 21.4 
Cefotaxime 13.0 4.5 22.0 9.3 28.2 26.2 
Cefuroxime 26.1 4.5 36.6 0.0 20.5 9.8 
Penicillin 10.9 11.4 12.2 11.6 10.3 11.9 
Vancomycin 0.0 0.0 0.0 0.0 30.8 11.9 
Protein 
Synthesis 
Inhibitor 
Chloramphenico
l 10.9 
9.1 0.0 0.0 0.0 0.0 
Erythromycin 13.0 9.1 19.5 0.0 30.8 0.0 
Gentamycin 23.9 20.5 26.8 9.3 41.0 4.8 
Tobramycin 26.1 6.8 29.3 2.3 20.5 9.5 
DNA 
Synthesis 
Inhibitor 
Ciprofloxacin 32.6 2.3 26.8 20.9 33.3 9.5 
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that have low resistance against antibiotics for 
human and animal use. From the results of the 
antibiotic susceptibility in the current study, 
obtained from a broad range of antibiotics, it was 
found that the isolated strains of Lactobacillus, 
Pediococcus and Enterococcus were resistant to 
various antibiotics. However, antibiotic resistance 
was lesser in strains obtained from infant fecal 
samples than adult fecal samples.  
Conclusion 
Lactobacillus, Pediococcus and Enterococcus as LAB 
were isolated from the human fecal samples 
exhibiting more antibiotic resistance from adult fecal 
isolate than the infant. The development of antibiotic 
resistancein LAB can be attributed to the long term 
exposure of antibiotic as therapeutic agents as well 
as food habits which pose food safety concerns. 
Thus, it is essential to see safety measure during 
antibiotic uptake in day to day life. In addition to 
this, the low antibiotic-resistant strains from infant 
could be the choice of strain to avoid the risk of 
transferof LAB linked antibiotic resistance to human 
pathogenic bacteria. 
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